
*The above chart is presented for indicative purposes only and may not be accurate. The figures represented above are taken on an average basis, and may or may not match with the prevailing situation. Users are requested to not completely rely on the above chart and to consult an independent financial adviser and to take their investment decisions.
❖ Origins & Evolution
● Established in 1996 in Kochi with a mission to bring high-quality healthcare to Kerala.
● Underwent a major transformation in 2016 when VPS Healthcare acquired a majority
stake, rebranding it to VPS Lakeshore.
● Backing from VPS and leadership of Dr. V. P. Shamsheer provided scale, capital, and
global healthcare expertise.
❖ Growing Footprint
● The hospital treated 3,38,651 out-patients and 21,022 in-patients during the year,
including 18,820 international out-patients and 373 international in-patients.
● Expanded beyond Kochi with a second medical centre in Kozhikode, treating 28,000+
patients, up from 24,000 last year. Demonstrates rising patient trust and regional brand
strength.
❖ Clinical & Infrastructure Strength
● Operates a 470-bed, state-of-the-art tertiary care hospital.
● Offers 30+ clinical specialties including transplants, oncology, neurology,
gastroenterology, joint replacement, and critical care.
● Equipped with advanced diagnostic & therapeutic technology.
● NABH accredited, ensuring top-tier quality and safety.
● Team includes 279 doctors, 814 nurses, and strong paramedical/support staff (CARE
Ratings, 2023).
● Large, skilled workforce enables high-end tertiary care services.
❖ Social Commitment & CSR
● CSR spend: ₹89 lakh + ₹17.37 lakh on ongoing projects.
● Focus areas: education, preventive healthcare, senior citizens, women’s welfare, care for
differently abled children, oncology support, and disaster relief (Wayanad).
● Provided ₹14.85 crore in treatment concessions to financially weaker patients.
| Dr Vayalil Parambath Shamsheer | Chairman |
| MR PM Sebastian | Chairman |
| Mr SK Abdulla | MD |
| Mr R Narayanan | CFO |
| INR in Cr | FY22 | FY23 | FY24 | FY25 |
| Operating Revenue | 359 | 419 | 396 | 408 |
| EBITDA | 83 | 102 | 73 | 71 |
| EBIT | 61 | 79 | 49 | 45 |
| EBT | 62 | 82 | 55 | 53 |
| PAT | 44 | 57 | 44 | 39 |
| EPS (INR) | 4.4 | 5.7 | 4.4 | 3.9 |
There is no restriction on transfer of unlisted shares until the IPO cut-off date which is generally a week before listing. However, after listing SEBI norms are applicable to these shares. As per SEBI regulations, all unlisted shares go in a lock-in period of 6 months from the date of listing of shares.
In case you have any queries, you may call us on +91 8958 212121 or write to us at [email protected]
All unlisted shares can be transferred only to Demat accounts. Unlisted shares can be checked in two ways:
1. Option 1
2. Option 2
You may also check the credit of your shares, by logging in to your Demat account and checking under DP Holdings in your respective DP.
In case you have any queries, you may call us on +91 8958 212121 or write to us at [email protected].
In the case of CDSL, the first 8 digits of your Demat Account Number are depository participant ID and the last 8 digits are your customer ID with the depository participant. The same goes for NSDL where ‘IN’, the 6 digits are depository participant ID and the rest of the numbers reflect your customer ID with a depository participant.
National Securities Depository Limited (NSDL): The Demat account number of NSDL starts with alphabets ‘IN’ followed by 14 numeric digits.
For e.g. IN30000012345678.
Central Depository Service Limited (CDSL) : The entire DEMAT account number of CDSL is numeric.
For e.g.1234567800001234
In case you have any queries, you may call us on +91 8958 212121 or write to us at [email protected].
The financials are available in the Research Report, DRHP, and Annual Reports of Chennai Super Kings (CSK) Unlisted Shares, which may be found under the Reports section of the company's specific page. You can download all the reports after logging in.
If you Liquidate the CSK unlisted shares within 2 years of its acquisition, then you will be required to pay tax on the short-term capital gain (STCG) as per the individual tax slab rate. Liquidating the shares after 2 years will attract a long-term capital gain (LTCG) which will be taxed at the rate of 12.5% without indexation benefits.
Investors should consult with an independent third-party taxation advisor prior to making investment decisions.
In case you have any queries, you may call us on +91 8958 212121 or write to us at [email protected]